🟠 Moderate Evidence
Taking iron supplements every other day rather than daily significantly improves how much iron your body absorbs, according to research published in Lancet Haematology. The finding challenges conventional supplementation wisdom and reveals how the body’s own regulatory hormones can sabotage daily iron dosing strategies.
Key takeaways
- Alternate-day dosing of 60 mg ferrous sulfate achieves 21.8% fractional absorption per dose versus 16.3% for consecutive daily doses
- Total iron absorbed over a course reaches 175 mg with alternate-day dosing compared to 131 mg with daily dosing—a 34% improvement
- The body’s hepcidin hormone, released after large iron doses, blocks intestinal iron export for about 24 hours, making back-to-back dosing inefficient
- The absorption advantage persists even in women with active iron-deficiency anemia, where hepcidin is already suppressed by the body’s demand for red blood cells
Study at a Glance
| Source | Lancet Haematology |
| Study type | Randomized controlled trial |
| Sample size | 40 iron-depleted women (initial study); separate cohort with iron-deficiency anemia (follow-up) |
| Population | Women with low iron stores and women with iron-deficiency anemia |
| Country | Not specified in source |
Iron Absorption Efficiency: Alternate-Day vs. Daily Dosing
Fractional absorption and cumulative iron uptake in women receiving 60 mg ferrous sulfate, Stoffel et al. 2017
Source: Stoffel et al., Lancet Haematology, 2017 | Georgian Medical Journal News
How the Body Blocks Iron on Daily Dosing
The mechanism is straightforward but powerful. When a person takes 60 mg or more of elemental iron—a standard supplementation dose—the liver responds by releasing hepcidin, a hormone that acts as an iron traffic controller. Hepcidin binds to ferroportin, the only protein channel that exports iron from intestinal cells (enterocytes) into the bloodstream. Once hepcidin locks onto ferroportin, the protein is degraded and removed from the cell surface.
The result: iron that has been absorbed into the enterocyte cannot exit. It remains trapped in the cell until the cell naturally sheds (every 3–5 days), and the iron is lost to the body. This hepcidin-induced ferroportin shutdown lasts approximately 24 hours. By 48 hours post-dose, hepcidin levels fall and ferroportin is resynthesized, restoring the cell’s ability to export iron.
According to research from Blood (Moretti et al., 2015), this is a homeostatic mechanism—the body’s way of preventing iron overload. But in iron-deficient patients seeking to replenish stores rapidly, it becomes a barrier to efficient absorption.
Alternate-Day Dosing Wins in Two Populations
In 2017, researchers led by Stoffel tested whether spacing doses 48 hours apart could circumvent this regulatory blockade. They enrolled 40 iron-depleted but non-anemic women and gave them either 60 mg ferrous sulfate daily or on alternate days. The alternate-day group absorbed 21.8% of each dose, compared to 16.3% for the daily group—a 34% relative improvement in absorption efficiency per dose.
Cumulative absorption over the full dosing course was even more striking: the alternate-day group absorbed 175 mg total, versus 131 mg for the daily group—a difference of 44 mg, or 34% higher total iron acquisition. This is a clinically meaningful gap. Faster iron repletion translates to quicker resolution of symptoms like fatigue and shorter treatment duration.
The stronger evidence emerged from a 2019 follow-up study (also published in Blood). This time, the team studied women with active iron-deficiency anemia—a population where the body’s hepcidin is already partially suppressed due to intense demand for red blood cells. Even in this group, where you might expect daily dosing to perform better, alternate-day dosing still achieved 40–50% higher fractional absorption per dose than daily dosing. The hepcidin rebound phenomenon persists as a rate-limiting step, even when systemic iron demand is high.
Caveats and Unknowns
All published studies on this topic used ferrous sulfate, one form of iron supplement. Whether the hepcidin rebound effect holds for other iron preparations—such as ferrous fumarate, ferric carboxymaltose, or plant-based iron compounds—remains untested. Similarly, both studies focused on women; whether men show the same absorption patterns is unknown. The mechanism is presumed to be universal, but direct evidence in men is absent.
Additionally, the studies enrolled women with low iron stores or iron-deficiency anemia. Results may not apply to individuals with normal iron levels who take supplements for other reasons, nor to people with hemochromatosis or other iron-overload disorders (for whom daily dosing should be avoided altogether).
Clinicians and patients should note that while alternate-day dosing improves fractional absorption, total iron delivered per dose is lower (60 mg every other day = 30 mg on average per calendar day, versus 60 mg daily). The net effect across longer treatment windows is still favorable for alternate-day regimens based on Stoffel’s data, but individual tolerability and preference matter too. See our Pharmacy & Prescribing section for more on iron supplementation strategies.
Alternate-day dosing of 60 mg ferrous sulfate achieves 21.8% fractional absorption per dose versus 16.3% for daily dosing, yielding 175 mg total absorbed versus 131 mg—a 34% improvement in cumulative iron acquisition.
— Stoffel et al., Lancet Haematology, 2017
What this means
Frequently asked questions
Why does the body release hepcidin after I take an iron supplement?
Hepcidin is part of your body’s built-in iron-regulation system. When iron levels rise (including after a supplement dose), the liver senses this and releases hepcidin to prevent iron overload by blocking intestinal iron export. This protective mechanism evolved to keep iron at healthy levels, but it inadvertently blocks absorption of subsequent supplemental doses taken within 24–48 hours.
Will alternate-day dosing work for me if I take other medications?
Iron interacts with many medications—including proton-pump inhibitors (which reduce stomach acid), tetracycline antibiotics, and certain osteoporosis drugs. Spacing doses 48 hours apart may actually reduce the risk of interactions by limiting simultaneous exposure. However, consult your pharmacist or doctor before changing your dosing schedule, as individual medication profiles vary. See our Pharmacy & Prescribing updates for more on drug interactions.
How long does it take to replenish iron stores on alternate-day dosing?
The timeline depends on how depleted your stores are and your individual absorption. The Stoffel studies (2017, 2019) measured absorption over single or multiple doses but did not report time-to-repletion. Work with your doctor to monitor iron levels (serum ferritin, hemoglobin) at regular intervals—typically 4–8 weeks into supplementation—to assess whether alternate-day dosing is achieving adequate repletion for you.
Alternate-day iron dosing represents a simple, evidence-backed adjustment to a common supplementation strategy. As research expands to include other iron forms, male populations, and diverse clinical settings, the case for dose-spacing may grow even stronger. For now, the data from Lancet Haematology and Blood provide solid ground for clinicians and patients to revisit dosing frequency in pursuit of better iron absorption and faster anemia correction.
Source: Iron supplements and hepcidin-mediated absorption: alternate-day versus daily dosing
Was this article helpful?
Disclaimer. This article is health journalism intended for general information and education. It is not medical advice and is not a substitute for professional diagnosis or treatment. Always consult a qualified healthcare provider about your individual circumstances. Full disclaimer →
Related Coverage
Editorial standards. This article was produced under the GMJ News editorial process, with oversight by the GMJ Editorial Board. Our editorial process. Spotted an error? Contact the editorial team.
